New hope for advanced cancer: ASKB589 trial underway
NCT ID NCT04632108
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study tests a new drug called ASKB589 in people with advanced or metastatic solid tumors, especially stomach and pancreatic cancers. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. About 199 participants will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing cancer hospital
Beijing, Beijing Municipality, 100089, China
-
Linyi cancer hospital
Linyi, Shandong, 276000, China
Conditions
Explore the condition pages connected to this study.